Literature DB >> 791863

Cyclophosphamide pretreatment and protection against malaria.

J F Finerty, E P Krehl.   

Abstract

Mice pretreated with cyclophosphamide were able to overcome infection from a lethal malarial strain. The development of resistance was preceded by increased hypersensitivity to malarial antigens. Hypersensitivity was demonstrable by a delayed footpad swelling technique.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791863      PMCID: PMC415498          DOI: 10.1128/iai.14.4.1103-1105.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Multiple modes of action of cyclophosphamide on plasmodial infections in rats.

Authors:  D T Spira; J Golenser; A Zuckerman; R Neiss
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

2.  B-cell suppression of delayed hypersensitivity reactions.

Authors:  S I Katz; D Parker; J L Turk
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

3.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

4.  Selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; L W Poulter
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

5.  Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes.

Authors:  W J Martin; J Finerty; A Rosenthal
Journal:  Nat New Biol       Date:  1971-10-27

6.  Antibody and immunoglobulin synthesis in germfree and conventional mice infected with Plasmodium berghei.

Authors:  J F Finerty; J E Tobie; C B Evans
Journal:  Am J Trop Med Hyg       Date:  1972-09       Impact factor: 2.345

7.  Effect of cyclophosphamide on Histoplasma capsulatum infections in mice.

Authors:  G C Cozad; T J Lindsey
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

8.  Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis.

Authors:  S H Singer; M Ford; R L Kirschstein
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

9.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

10.  Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  14 in total

1.  Plasmodium chabaudi in mice. Adoptive transfer of immunity with enriched populations of spleen T and B lymphocytes.

Authors:  V McDonald; R S Phillips
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

2.  Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship.

Authors:  T E Miller
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

3.  Cell-mediated immunity in mice vaccinated against malaria.

Authors:  B J Cottrell; J H Playfair; B J De Souza
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

4.  Delayed-type hypersensitivity in mice immunized with Trypanosoma rhodesiense antigens.

Authors:  J F Finerty; E P Krehl; R L McKelvin
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

5.  Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum.

Authors:  D W Roberts; R G Rank; W P Weidanz; J F Finerty
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

6.  Host defenses in murine malaria: evaluation of the mechanisms of immunity to Plasmodium yoelii infection.

Authors:  J R Murphy; M J Lefford
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Authors:  M S Ascher; P B Jahrling; D G Harrington; R A Kishimoto; V G McGann
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

8.  Pharmacological modulation of suppressor cell activity in mice with disseminated histoplasmosis.

Authors:  G S Deepe; G R Kravitz; W E Bullock
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Two distinct types of non-specific immunosuppression in murine malaria.

Authors:  R Lelchuk; J H Playfair
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

10.  Lack of correlation between delayed-type hypersensitivity and host resistance to Plasmodium chabaudi infection.

Authors:  V McDonald; I W Sherman
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.